NanoGroup S.A. (NNG.WA)

PLN 2.37

(-1.25%)

Gross Profit Summary of NanoGroup S.A.

  • NanoGroup S.A.'s latest annual gross profit in 2023 was -79.01 Thousand PLN , down -280.55% from previous year.
  • NanoGroup S.A.'s latest quarterly gross profit in 2024 Q2 was 8000.00 PLN , up 100.76% from previous quarter.
  • NanoGroup S.A. reported a annual gross profit of 43.76 Thousand PLN in annual gross profit 2022, down -85.73% from previous year.
  • NanoGroup S.A. reported a annual gross profit of 306.59 Thousand PLN in annual gross profit 2021, down -53.29% from previous year.
  • NanoGroup S.A. reported a quarterly gross profit of -1.05 Million PLN for 2024 Q1, down -246.77% from previous quarter.
  • NanoGroup S.A. reported a quarterly gross profit of -230 Thousand PLN for 2023 Q3, down -66.67% from previous quarter.

Annual Gross Profit Chart of NanoGroup S.A. (2023 - 2015)

Historical Annual Gross Profit of NanoGroup S.A. (2023 - 2015)

Year Gross Profit Gross Profit Growth
2023 -79.01 Thousand PLN -280.55%
2022 43.76 Thousand PLN -85.73%
2021 306.59 Thousand PLN -53.29%
2020 656.32 Thousand PLN 96.75%
2019 333.58 Thousand PLN 293.66%
2018 84.73 Thousand PLN 284.02%
2017 -46.04 Thousand PLN 21.15%
2016 -58.4 Thousand PLN -4295.55%
2015 1392.00 PLN 0.0%

Peer Gross Profit Comparison of NanoGroup S.A.

Name Gross Profit Gross Profit Difference
Bioceltix S.A. -1.03 Million PLN 92.388%
BIOTON S.A. 72.85 Million PLN 100.108%
Captor Therapeutics Spolka Akcyjna 6.9 Million PLN 101.145%
Mabion S.A. 114.58 Million PLN 100.069%
Molecure S.A. -4.1 Million PLN 98.074%
Pharmena S.A. 5.84 Million PLN 101.352%
Poltreg S.A. -1.38 Million PLN 94.303%
Pure Biologics Spólka Akcyjna -2.57 Million PLN 96.93%
Ryvu Therapeutics S.A. 29.3 Million PLN 100.27%
Synthaverse S.A. 35.16 Million PLN 100.225%
Urteste S.A. -479 Thousand PLN 83.504%